Exponent, Inc.

Exponent, Inc. (EXPO) Market Cap

Exponent, Inc. has a market capitalization of $3.24B.

Price: $66.85

2.28 (3.53%)

Market Cap: 3.24B

NASDAQ · time unavailable

CEO: Catherine Ford Corrigan

Sector: Industrials

Industry: Engineering & Construction

IPO Date: 1990-08-17

Website: https://www.exponent.com

Exponent, Inc. (EXPO) - Company Information

Market Cap: 3.24B|Sector: Industrials

Company Profile

Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.

Analyst Sentiment

79%
Strong Buy

From 4 Active Polls

1Y Forecast: $72.00

▲ +7.7% Potential Upside

Consensus Target Metrics

Low Bound

$72

Median

$72

High Bound

$72

Average

$72

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$72.00
▲ +7.70% Upside
Low Target
$72.00
8% Risk
Median Target
$72.00
8% Mid
High Target
$72.00
8% Max
Consensus
Buy
6 / 8 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q3 2024
Period EndingTrailing 12MJul 3, 2026Apr 3, 2026Jan 2, 2026Oct 3, 2025Jul 4, 2025Apr 4, 2025Jan 3, 2025Sep 27, 2024
Market Cap ($M)3,2432,9733,3143,5273,4303,9503,9524,5545,796
Enterprise Value ($M)3,2572,9873,2773,3883,3053,7993,7874,3765,657
Price to Earnings Ratio (P/E)40.761524.5028.2035.7930.5037.0737.0548.3255.51
Price/Earnings-to-Growth Ratio (PEG)2.20172.648.395.80135.22
Price to Sales Ratio (P/S)11.01-17.8819.9323.9223.3127.8327.1633.2942.53
Price to Book Ratio (P/B)11.2910.309.809.048.519.238.9510.8114.13
Price to Free Cash Flow Ratio (P/FCF)28.60-966.7566.68114.41116.36715.9285.18206.99
Enterprise Value to Sales (EV/Sales)-17.9619.7022.9822.4626.7626.0332.0041.51
Enterprise Value to EBITDA (EV/EBITDA)27.47-730.6973.0592.4580.3296.5794.08129.40147.60
Debt to Equity Ratio0.120.280.240.210.210.190.180.190.20

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 EXPONENT INC (EXPO) — Investment Overview

🧩 Business Model Overview

Exponent is an independent science and engineering consulting firm that supports corporate decision-making and disputes. Work is delivered through multidisciplinary teams—typically spanning materials science, biomechanics, chemistry, electrical/optical technologies, software-informed analysis, regulatory practice, and forensic investigation. Clients engage Exponent for technically rigorous studies, expert reports, testing, failure analysis, and litigation support, then often expand scope through follow-on analyses as matters mature.

The practical value chain is: (1) intake of technical and legal/engineering requirements, (2) hypothesis-driven analysis supported by lab/testing and expert methodologies, (3) documented outputs used by clients internally (risk, design, compliance) or externally (expert testimony, claims resolution), and (4) project completion and reuse of expert teams for future matters. This creates client stickiness driven by credibility and continuity of technical teams rather than recurring SaaS-style billing.

💰 Revenue Streams & Monetisation Model

Exponent monetizes primarily through professional services, with revenue generated from billed engagements (often tied to consulting hours, day rates, and project-based milestones). Monetisation is closely linked to:

  • Utilization and staffing mix: revenue scales with billable capacity and the ability to staff complex matters with senior experts.
  • Engagement complexity: higher technical and regulatory complexity typically supports higher effective pricing per engagement.
  • Repeat usage and expansion: customers that repeatedly face product-safety, regulatory, or IP disputes may broaden scope across new investigations and jurisdictions.

Margin structure is driven by gross margin from professional delivery (labor efficiency, utilization) and operating leverage from SG&A discipline. While projects are discrete, a meaningful portion of demand can be “relationship-driven,” enabling management to protect margins through disciplined forecasting of staffing requirements and retention of key subject-matter experts.

🧠 Competitive Advantages & Market Positioning

Exponent’s moat is primarily an intangible-asset and switching-cost dynamic: specialized scientific credibility, documented methodologies, and the depth of expert talent that clients rely on for high-stakes outputs. Once a team becomes embedded in a client’s technical fact pattern, the effort required to replicate equivalent expertise (and credibility with courts, regulators, and opposing counsel) raises switching frictions.

  • Intangible assets (credibility + expertise): independent expert work depends on demonstrated technical rigor, defensible analysis, and experience in expert reporting and adjudication contexts. Building comparable capability takes years.
  • Switching costs (continuity of experts and technical context): transferring a matter to another firm means re-learning proprietary designs, historical testing, and legal/technical context—costly in both time and risk.
  • Reputation as a constraint on competitors: opponents and courts evaluate competence and consistency; this naturally filters the set of firms that can win repeat work.

Competitive benchmarking:

  • Charles River Associates (CRA): CRA is more concentrated in economic consulting and valuation/strategy-adjacent services, whereas Exponent is anchored in science, engineering, and technical expert deliverables.
  • FTI Consulting: FTI offers broader multidisciplinary dispute and investigations capabilities, including technical services, but Exponent differentiates through a denser focus on scientific and engineering analysis as a core competency.
  • Guidehouse: Guidehouse spans consulting across regulatory, technology, and engineering domains; Exponent is more specialized in technical expert support tied to product, safety, and failure analysis.

Overall, Exponent’s industry focus tends to emphasize high-technical-fidelity expert work where credibility and domain depth matter more than breadth.

🚀 Multi-Year Growth Drivers

A 5–10 year outlook for Exponent is supported by secular drivers that increase the need for rigorous technical analysis:

  • Rising technical complexity: electrification, advanced materials, semiconductors, medical device innovation, and software-enabled systems raise the difficulty of failure analysis, safety validation, and regulatory compliance.
  • Greater regulatory and compliance volume: evolving standards across product categories and jurisdictions increases demand for engineering-backed risk assessments and documentation.
  • Ongoing litigation and dispute resolution activity: product liability, IP disputes, and commercial claims frequently require expert scientific and engineering testimony.
  • Globalization of standards and supply chains: multinational product portfolios and vendor networks expand the number of technical fact patterns requiring specialized expert support.

These forces expand the addressable market not by replacing existing expert services, but by increasing the frequency and sophistication of matters that demand defensible technical work.

⚠ Risk Factors to Monitor

  • Litigation and dispute cycle variability: demand can fluctuate with legal environment, corporate claim filing behavior, and client budget cycles.
  • Talent retention and capacity constraints: margins and growth depend on sustaining senior expert depth; competition for highly specialized scientists and engineers can pressure staffing and utilization.
  • Technology disruption (AI-enabled analysis): AI can accelerate certain components of analysis, but expert credibility, experimental validation, and defensible reporting remain difficult to fully automate.
  • Client concentration and procurement shifts: large client contracting strategies can affect engagement size, duration, and pricing terms.
  • Reputation and quality risk: expert work is high-stakes; errors or perceived weaknesses can impair future win rates and partner selection.

📊 Valuation & Market View

Equity markets typically value professional services and expert advisory firms using EV/EBITDA, earnings multiples, and sometimes revenue multiples when visibility and margin structure are stable. Key valuation drivers include:

  • Operating margin durability: the market rewards firms that sustain utilization efficiency and labor productivity.
  • Growth quality: growth supported by repeat relationships and higher-complexity engagements tends to deserve a premium to more cyclical, one-off demand.
  • Capital efficiency and cash conversion: professional firms with predictable working capital dynamics can command steadier multiples.
  • Evidence of demand resilience: consistent backlog and the ability to staff complex projects without margin dilution.

A negative re-rating typically occurs when utilization weakens, expert retention becomes challenging, or margin structure deteriorates due to staffing inefficiency or pricing pressure.

🔍 Investment Takeaway

Exponent’s long-term thesis rests on a structural expertise-driven moat: deep scientific and engineering capability combined with credibility and switching costs that arise in high-stakes technical disputes and regulatory/compliance settings. Demand tailwinds stem from increasing product and regulatory complexity, which raises the need for defensible technical analysis. Investors should underwrite for capacity, talent retention, and margin resilience while monitoring litigation cycle dynamics and quality/reputation risk.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for EXPO.

seekingalpha.com2026-07-30

Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript

Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript

marketbeat.com2026-07-30

Exponent Q2 Earnings Call Highlights

Exponent NASDAQ: EXPO reported double-digit revenue and earnings growth for the second quarter of 2026, supported by demand for user research involving artificial intelligence-enabled products, utility-sector risk management work, and dispute-related consulting across consumer products, chemicals and transportation.

zacks.com2026-07-30

Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates

Exponent (EXPO) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.52 per share a year ago.

globenewswire.com2026-07-30

Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million

MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on September 18, 2026, to all common stockholders of record as of September 4, 2026.

globenewswire.com2026-07-30

Exponent Reports Second Quarter 2026 Financial Results

MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.

globenewswire.com2026-07-09

Exponent to Announce Second Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on July 30, 2026

MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.

seekingalpha.com2026-07-07

Exponent: AI Makes The Work More Complex, Not Less Valuable

Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO's value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO's services, not diminish it.

globenewswire.com2026-06-17

Exponent to Host Investor Day at Phoenix Test & Engineering Center

Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy

globenewswire.com2026-06-05

Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference

MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:

seekingalpha.com2026-05-04

Exponent: Rising Demand And A Reasonable Valuation Make It A Buy

Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO's fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price.

seekingalpha.com2026-05-01

Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript

Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript

zacks.com2026-04-30

Exponent (EXPO) Surpasses Q1 Earnings and Revenue Estimates

Exponent (EXPO) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.52 per share a year ago.

globenewswire.com2026-04-30

Exponent Reports First Quarter 2026 Financial Results

MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026.

globenewswire.com2026-04-30

Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million

MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on June 18, 2026 to all common stockholders of record as of June 5, 2026.

defenseworld.net2026-04-25

Evergreen Capital Management LLC Takes $770,000 Position in Exponent, Inc. $EXPO

Evergreen Capital Management LLC purchased a new stake in shares of Exponent, Inc. (NASDAQ: EXPO) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,081 shares of the business services provider's stock, valued at approximately $770,000. Several other hedge funds and other

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-04-03

"EXPO reported Q1 2026 Revenue of $166.3M and Net Income of $29.6M (EPS $0.59). QoQ, revenue rose to 2026-04-03 from $147.4M in 2026-01-02 (+12.8%), and net income increased from $24.8M (+19.4%). YoY, Q1 2026 revenue improved from $145.5M in 2025-04-04 (+14.3%), while net income was roughly flat at $26.7M (+10.9%). Profitability improved: gross margin expanded to 28.6% from 24.3% in the prior quarter and from 94.5% a year ago (the latter appears anomalous), while net margin edged up to 17.8% (from 16.8% QoQ). Operating income grew to $41.4M (operating margin 24.9%), reflecting better operating leverage. Cash flow weakened materially. Operating cash flow was -$1.0M and free cash flow was -$3.4M, contrasting sharply with positive OCF of $55.6M in Q4 2025. The company returned capital aggressively (Q1 buybacks of ~$78.8M and dividends of ~$16.6M), which drove a $103.4M decline in cash to $118.6M. Balance-sheet resilience remains decent with positive equity of $338.3M and net cash (net debt of -$37.5M), though total assets fell QoQ from $808.6M. Shareholder returns appear mixed: the stock is down -14.3% over 1 year, so total-return momentum is a headwind versus valuation targets (consensus target $85)."

Revenue Growth

Positive

Revenue increased +12.8% QoQ (to $166.3M) and +14.3% YoY (from $145.5M), indicating solid top-line momentum into Q1 2026.

Profitability

Neutral

Net income rose +19.4% QoQ (+10.9% YoY) and net margin improved to 17.8% from 16.8% QoQ, suggesting margin stability-to-improvement (notwithstanding an anomalous YoY gross margin comparison).

Cash Flow Quality

Neutral

Cash flow deteriorated sharply: operating cash flow was -$1.0M and free cash flow -$3.4M in Q1 2026 vs +$55.6M OCF in Q4 2025, even as dividends and buybacks continued.

Leverage & Balance Sheet

Neutral

Financial resilience looks adequate with positive equity of $338.3M and net cash position (net debt -$37.5M). However, cash declined and total assets fell QoQ.

Shareholder Returns

Caution

Despite meaningful capital returns (buybacks and dividends), market performance is negative: 1-year change -14.3%, which lowers total-return momentum.

Analyst Sentiment & Valuation

Fair

Consensus price target is $85 vs current price $68.05 (upside implied), but the market has been trending down over the last year, suggesting valuation optimism not yet reflected in price.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Exponent’s Q2 2026 results show strong organic momentum driven by AI-enabled product development and escalating technical risk across real-world systems. Net revenues grew 12% YoY to $148.9M, with diluted EPS up 15% to $0.60. Operating leverage improved: EBITDA margin rose to 28.7% (+90 bps) and utilization increased to 74% (+200 bps), despite higher corporate infrastructure and G&A costs. A key contributor was a large user research study that expanded from an expected ~2% to ~4% of net revenues, supporting both higher revenue and utilization. Management raised full-year 2026 guidance: net revenues +9%-10% and EBITDA margin 27.8%-28.1%, with Q3 EBITDA margin targeted at 28.0%-28.5%. The Q&A reinforced that AI demand spans both proactive and reactive work, especially ADAS-related litigation (including driver monitoring/distraction) and data-center failure analysis, while proactive user research is positioned as a differentiating, pricing-relevant “moat” through bespoke experimental design and regulatory/legal integration.

AI IconGrowth Catalysts

  • Proactive user research studies expanding in scope/scale/complexity, supported by AI-enabled product development across diverse hardware form factors
  • Large user research study drove higher-than-expected revenue/utilization; expected to continue into remainder of year
  • Increased risk management and infrastructure-related engagements in the utility sector amid grid complexity and extreme weather/power demand
  • Reactive dispute and failure analysis demand across consumer products, chemicals, and transportation; including advanced driver assistance system (ADAS) investigations and satellite performance issue

Business Development

    AI IconFinancial Highlights

    • Total revenues +21% YoY to $171.6M; net revenues (before reimbursements) +12% YoY to $148.9M (reimbursables increased due to higher user research study mix)
    • Diluted EPS +15% YoY to $0.60 ($0.52 prior year)
    • Net income +11% YoY to $29.4M
    • EBITDA margin expanded to 28.7% of net revenues from 27.8%: +90 bps YoY
    • Utilization improved to 74% from 72%: +200 bps YoY
    • Realized rate increased ~4% in Q2
    • Tax rate 27.9% in Q2 unchanged YoY; management guided tax rate ~28% for Q3 and 28.5% for full-year 2026 (vs 28.0% in 2025)
    • Large user research study represented ~4% of net revenues vs 2% expected from that project

    AI IconCapital Funding

    • Share repurchases: $67.4M during Q2 at average $59.88
    • Dividend payments: $14.8M during Q2
    • Trailing 12 months capital return: $211M repurchases + $61M dividends = $272M
    • Board approved +$50M increase to current stock repurchase program
    • Cash impact: interest income decreased to $716k for Q2 driven by decreased cash
    • Capital expenditures: $1.8M in Q2; full-year CAPEX expected $12M-$14M

    AI IconStrategy & Ops

    • User research delivery model emphasizing bespoke experiment design, scientific question definition, real-world data collection, and interpretation within regulatory/legal/business context (differentiation vs commodity data collection)
    • Aggressive hiring in human factors, biomechanics, data science, and engineering to broaden user research moat
    • Other operating expenses up 7% to $12.9M due to corporate infrastructure investments
    • G&A up 20% to $7.4M driven by travel/meals for business development/recruiting/people development and relocation costs

    AI IconMarket Outlook

    • Q3 2026 guidance: net revenues +8%-10% YoY; EBITDA margin 28.0%-28.5% of net revenues
    • Q3 2026 utilization: 74%-75%; full-year utilization: 72.5%-73%
    • Q3 realized rate increase: 3%-4%; full-year realized rate increase: 3.5%-4%
    • Full-year 2026 guidance raised: net revenues +9%-10%; EBITDA margin 27.8%-28.1%
    • Headcount growth: technical full-time equivalents +4%-5% YoY in Q3; +4.5%-5% for full year
    • Stock-based compensation: Q3 $6.5M-$6.7M; full-year $27.9M-$28.4M
    • Tax rate: Q3 ~28% (vs 27.4% prior year quarter); full-year 2026 ~28.5% (vs 28.0% in 2025)
    • Interest income: $500k-$700k per quarter remainder of 2026; miscellaneous income ~ $300k per quarter remainder of 2026

    AI IconRisks & Headwinds

    • Utilization assumptions tied to timing of available working days; Q4 typically impacted by holidays/vacations with lower utilization each year
    • Competition: management noted aggressive industry competition may pressure commodity layers, requiring pricing to reflect differentiation and scale/complexity
    • Tax rate normalization risk: guidance implies a step-up to 28.5% full-year 2026 vs 28.0% in 2025

    Q&A: Analyst Interest

    • AI demand mix: Management said AI impacts both reactive and proactive work, with reactive strongest in ADAS-related litigation (performance plus driver distraction/monitoring human-machine interface). Also highlighted data-center reactive investigations (cooling, inverters, battery energy storage/fire/code) and proactive user research tied to embedded AI, spanning human factors and algorithm performance.
    • User research driver quantification + utilization: Management quantified the Q2 user experience growth: a large study expanded from an expected ~2% of net revenues to ~4% during Q2, moderated late quarter. Expected to continue the next part at ~2% net revenues through the remainder of the year; higher utilization benefited, but Q3 utilization modeled as slightly higher due to normal seasonality.
    • Differentiation/price power amid complexity: Management argued the user research domain has broadening “competitive moat,” moving beyond commodity survey/data collection to bespoke experiment design, right scientific question definition, and end-to-end regulatory/legal/business implications. Management described hiring aggressively in human factors/biomechanics/data science and tied pricing reflection to articulated value despite competitive speed of innovation.

    Sentiment: POSITIVE

    Note: This summary was synthesized by AI from the EXPO Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    📋 Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for EXPO.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    📁

    SEC Filings (EXPO)

    © 2026 Stock Market Info — Exponent, Inc. (EXPO) Financial Profile